MeSH tree: D12.776.049.407.249
Alzheimer's disease is the most common form of dementia worldwide, and its development is influenced by a combination of genetic and environmental factors. In recent years, the PLCG2 gene and its encoded enzyme, PLCγ2, have ...
Aug 17, 2026
0
6
A compound produced by bacteria in many people's digestive tracts increases the risk of developing Alzheimer's disease and speeds cognitive decline in dementia patients, making it a potential target for a treatment that could ...
Aug 13, 2026
0
783
An experimental drug might help slow early Alzheimer's disease in a markedly different way than today's treatments—by lowering levels of a brain protein called tau, researchers reported Tuesday.
Jul 14, 2026
0
43
Researchers at the USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC analyzed brain imaging and clinical data from more than 17,000 participants across five ...
Jun 17, 2026
0
3
Monash University researchers have found in laboratory experiments that a drug that delivers copper to the brain significantly reduces toxic Alzheimer's proteins and improves long-term spatial memory.
Jun 15, 2026
1
234
An international collaboration of genetic researchers has identified more than 90 genetic regions associated with the risk of Alzheimer's disease and related dementias. The large-scale meta-analysis reveals new biological ...
Jun 4, 2026
0
11
When a person goes into deep sleep, waterlike fluid circulates around the brain, washing away metabolic waste that is linked to diseases such as Alzheimer's. This process, known as the glymphatic system, was first described ...
May 27, 2026
0
47
Why are conditions such as chronic stress, depression, cardiovascular disease, fragmented sleep, and aging all associated with a higher risk of dementia? In a new review piece in Science, University of Rochester Medicine ...
May 21, 2026
0
32
For the first time, therapeutically effective medications are now available for Alzheimer's disease. Effective symptomatic therapies also exist for Parkinson's disease; however, a prerequisite for successful treatment is ...
May 21, 2026
0
10
A statistical approach being used to support a new class of Alzheimer's drugs may lead to overstated claims about how the drugs work, according to a new study led by researchers at the Brown University School of Public Health.
May 18, 2026
0
17
